Answers are grounded in this paper and cite their sources.
This study evaluated the chemical composition and antibacterial activity of Struchium sparganophorum (L.) Kuntze extracts against Staphylococcus aureus. Phytochemical screening, GC–MS, UPLC–MS/MS, in vitro antibacterial assays, and in silico analyses were used to identify active constituents and explore possible mechanisms. The ethyl acetate extract (EtOAc) showed a richer metabolite profile than the ethanol extract (EtOH), with 72 compounds versus 51, and a notable enrichment of terpenoids. In UPLC–MS/MS analysis, akebonoic acid (AKA) was the dominant triterpenoid, representing 25.18% in EtOAc compared with 3.04% in EtOH. EtOAc displayed antibacterial activity (MIC = 1250 µg/mL) and inhibited bacterial growth in a concentration-dependent manner against a single S. aureus strain under in vitro conditions. The EtOAc extract reduced biofilm formation by 92.30 ± 2.75% at 0.25 × MIC (312.5 µg/mL). SEM analysis indicated membrane damage. Molecular docking suggested AKA may target virulence- and cell wall-related proteins. Overall, EtOAc extract, particularly AKA, is a promising antibacterial and antibiofilm candidate.
No takes yet. Share an insight, caveat, or question.
Vo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: